Acumen Pharmaceuticals (ABOS) Earnings Date & Reports

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ABOS is expected to report earnings to fall 18.23% to -50 cents per share on May 20

Acumen Pharmaceuticals ABOS Stock Earnings Reports

Q1'25

Est.

$-0.51

Q4'24

Missed

by $0.13

Q3'24

Missed

by $0.14

Q2'24

Missed

by $0.07

Q1'24

Beat

by $0.01

The last earnings report on March 27 showed earnings per share of -62 cents, missing the estimate of -49 cents. With 280.02K shares outstanding, the current market capitalization sits at 59.76M.

View a ticker or compare two or three

Compare

ABOS